# Soleus Capital: portfolio, investments and team

> Soleus Capital is a private equity based in United States. 5 investments on record, 3 in the last 12 months, latest Oct 2026.

Source: https://millionrounds.com/fund/soleus-capital (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Soleus Capital

Last cheque observed Oct 2026; 5 cheques on record.

Email

Private equity Deploying now New fund $1.5B, Aug 2026

Seed Series A Series B Biotech Medtech Diagnostics

Follow Soleus Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fsoleus-capital)

Deploying now

**100%** of best year **3** **cheques in 12 months**, 5 on record

Since the last cheque **11** days **00** hrs **00** min **00** sec

Median round **$120M** Rounds led **0 of 5**

Pitch Soleus Capital

## Soleus Capital highlights

- 01 3 cheques in the last 12 months
- 02 Mostly Series B and Series C: 100% of its rounds

## What they do

> We invest across the healthcare lifecycle from developmental-stage companies through commercial companies. From their own website

- **Type:** Private equity (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth
- **Sectors:** Biotech Medtech Diagnostics
- **Based in:** Greenwich, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **5 appearances**

- **2026** 3 rounds
- **Oct** **[Bolt Biotherapeutics](https://millionrounds.com/company/bolt-biotherapeutics)** US · Pulse 2.0 **$120M** With 11 others
- **Oct** **[Star Therapeutics](https://millionrounds.com/company/star-therapeutics)** US · Pulse 2.0 **$200M** With 10 others
- **Jul** **[Crystalys Therapeutics](https://millionrounds.com/company/crystalys-therapeutics)** Series B · Frazier Life Sciences **$130M** With 10 others
- **2019** 1 round
- **Dec** **[ArcherDx](https://millionrounds.com/company/archerdx)** Series C · US · FinSMEs **$55M** With 8 others
- **2018** 1 round
- **Sept** **[Lyra Therapeutics](https://millionrounds.com/company/lyra-therapeutics)** Series B · US · FinSMEs **$30M** With 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **10 named**

BA **Benjamin Andrew Lund** Limited Partner i Form ADV

BJ **Benoit J. Sansoucy** Director i Filing they signed

DA **David Allen Canner** Limited Partner i Form ADV

DC **Derek Candy** Director i Filing they signed

GB **Guy Bezalel Levy** Mr. Levy is the Chief Executive Officer and Chief Investment Officer of the General Partner of the Issuer and the Chief Investment Officer of the Management Company i Filing they signed

HJ **Harold James Schaaff** General Counsel; Chief Compliance Officer i Form ADV

KJ **Kim J. Bishop** Director i Filing they signed

KJ **Kimberly J. Melen** Director i Filing they signed

MA **Michael Anthony Coppola** Chief Financial Officer i Form ADV

SJ **Steven Joseph Musumeci** Mr. Musumeci is the Chief Operating Officer of both the General Partner and the Investment Manager Company i Filing they signed

We also hold **10** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$3.7B** assets it manages Oct 2026

**Registered** investment adviser full reporting to the SEC

- **Legal name:** Soleus Capital Management, L.P.
- **SEC number:** CRD 294459

Funds on its Form ADV

**6** private funds, **$2.0B** in gross assets · filed Jul 2024

Private equity **4** Hedge **2**

- Soleus Capital Master Fund, L.P. *Hedge* 471 investors $1.6B
- Soleus Private Equity Fund III, L.P. *Private equity* 108 investors $195M
- Soleus Private Equity Fund II, L.P. *Private equity* 125 investors $181M
- Soleus Private Equity Fund I, L.P. *Private equity* 59 investors $25M
- Soleus BB SPV, LLC *Private equity* 32 investors $8.5M
- Soleus Capital Special Opportunities Fund, L.P. *Hedge* 42 investors $7.2M

New fund on file

**$1.5B**

raised in Aug 2026

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Seed Series A Series B

Median round joined **$120M** the round, not its cheque

Led 0 of 5 rounds **0%**

- **Sole investor:** Never alone
- **Last cheque:** Oct 2026

Rounds by stage said on their site

- Series B said *2*
- Series C *1*
- Seed said *-*
- Series A said *-*
- Growth said *-*

Cheques by month Led Joined

Dec 2023 Nov 2026

Often in the room with

- [ArrowMark Partners](https://millionrounds.com/fund/arrowmark-partners) 2
- [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) 2

**Pitching Soleus Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Soleus Capital. A count of rooms they were both in, not a relationship either has claimed.

[**ArrowMark Partners** Private equity **2** rounds together](https://millionrounds.com/fund/arrowmark-partners)[**Cormorant Asset Management** Private equity **2** rounds together](https://millionrounds.com/fund/cormorant-asset-management)

## Recently backed

The latest companies Soleus Capital put money into.

[**Star Therapeutics** $200M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**ArcherDx** $55M · Dec 2019](https://millionrounds.com/company/archerdx)[**Lyra Therapeutics** $30M · Sept 2018](https://millionrounds.com/company/lyra-therapeutics)

## Quick answers about Soleus Capital

### What does Soleus Capital invest in?

Soleus Capital invests most often at Series B and Series C (100% of the rounds on record), in sectors such as Biotech, Medtech and Diagnostics.

### How active is Soleus Capital?

5 investments on record, 3 of them in the last 12 months. The most recent was in Oct 2026.

### What has Soleus Capital invested in recently?

Its most recent investments on record: Bolt Biotherapeutics (Undisclosed round, Oct 2026), Star Therapeutics (Undisclosed round, Oct 2026) and Crystalys Therapeutics (Series B, Jul 2026).

### How big are Soleus Capital's cheques?

The median round it joins is $120M.

### Does Soleus Capital lead rounds?

Rarely, if at all: none of its 5 investments on record names it as the lead.

### Is Soleus Capital investing now?

Yes: it is actively investing, with 3 investments in the last 12 months.

### Who does Soleus Capital invest alongside?

Most often ArrowMark Partners (2 rounds together) and Cormorant Asset Management (2 rounds together).

### What kind of investor is Soleus Capital?

Soleus Capital is a private equity firm based in Greenwich, United States.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=soleus-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=soleus-capital)
